Goldman Sachs Group Inc Glaukos Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Glaukos Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 310,108 shares of GKOS stock, worth $43.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
310,108
Previous 218,717 41.79%
Holding current value
$43.1 Million
Previous $25.9 Million 56.07%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$113.62 - $135.39 $10.4 Million - $12.4 Million
91,391 Added 41.79%
310,108 $40.4 Million
Q2 2024

Aug 13, 2024
SELL
$89.48 - $118.35 $1.05 Million - $1.39 Million
-11,703 Reduced 5.08%
218,717 $25.9 Million
Q1 2024

May 15, 2024
BUY
$76.4 - $96.33 $7.93 Million - $10 Million
103,778 Added 81.95%
230,420 $21.7 Million
Q4 2023

Feb 13, 2024
BUY
$59.53 - $85.11 $1.11 Million - $1.59 Million
18,639 Added 17.26%
126,642 $10.1 Million
Q3 2023

May 14, 2024
SELL
$69.23 - $79.09 $1.29 Million - $1.47 Million
-18,639 Reduced 14.72%
108,003 $8.13 Million
Q3 2023

Nov 14, 2023
SELL
$69.23 - $79.09 $1.11 Million - $1.27 Million
-16,032 Reduced 12.93%
108,003 $8.13 Million
Q2 2023

May 14, 2024
SELL
$45.44 - $71.21 $4.18 Million - $6.55 Million
-92,034 Reduced 42.59%
124,035 $8.83 Million
Q2 2023

Aug 14, 2023
SELL
$45.44 - $71.21 $4.18 Million - $6.55 Million
-92,034 Reduced 42.59%
124,035 $8.83 Million
Q1 2023

May 14, 2024
BUY
$43.88 - $52.48 $1.56 Million - $1.87 Million
35,591 Added 19.72%
216,069 $10.8 Million
Q1 2023

May 11, 2023
BUY
$43.88 - $52.48 $1.56 Million - $1.87 Million
35,591 Added 19.72%
216,069 $10.8 Million
Q4 2022

May 14, 2024
SELL
$40.82 - $57.75 $6.84 Million - $9.67 Million
-167,488 Reduced 48.13%
180,478 $7.88 Million
Q4 2022

Feb 13, 2023
SELL
$40.82 - $57.75 $6.84 Million - $9.67 Million
-167,488 Reduced 48.13%
180,478 $7.88 Million
Q3 2022

May 14, 2024
BUY
$46.84 - $58.49 $1.15 Million - $1.43 Million
24,499 Added 7.57%
347,966 $18.5 Million
Q3 2022

Nov 10, 2022
BUY
$46.84 - $58.49 $1.15 Million - $1.43 Million
24,499 Added 7.57%
347,966 $18.5 Million
Q2 2022

May 14, 2024
BUY
$34.86 - $63.77 $6.86 Million - $12.6 Million
196,825 Added 155.42%
323,467 $14.7 Million
Q2 2022

Aug 15, 2022
BUY
$34.86 - $63.77 $4.71 Million - $8.61 Million
134,989 Added 71.62%
323,467 $14.7 Million
Q1 2022

May 16, 2022
SELL
$44.33 - $57.82 $1.55 Million - $2.02 Million
-34,877 Reduced 15.62%
188,478 $10.9 Million
Q4 2021

Feb 14, 2022
BUY
$40.27 - $56.99 $3.41 Million - $4.82 Million
84,586 Added 60.95%
223,355 $9.93 Million
Q3 2021

Nov 10, 2021
BUY
$47.43 - $84.23 $6.58 Million - $11.7 Million
138,769 New
138,769 $6.69 Million

Others Institutions Holding GKOS

# of Institutions
342
Shares Held
47.1M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.62B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email